Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...

Korro Bio disclosed that the Food and Drug Administration granted orphan drug designation to its potential genetic disorder drug KRRO-110. Shares rose 17.6% to $29 in premarket trading. The stock is ...

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

COVID and the 1918 flu pandemic gave us playbooks on how to prepare for the next pandemic. But we aren’t using it.

A Kiowa man who nearly lost his battle with COVID-19 returned to the ICU where he spent two months to thank the care team ...

Many people believe that only active smokers are at risk of smoking-related diseases. However, passive smoking—breathing in ...

The people of Rainham in east London are bracing themselves for fire season. Under Arnolds Field on Launders Lane, tonnes of ...

People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.